The Center for Infectious Disease Research and Policy (CIDRAP) yesterday published an interesting summary of the public discourse on the BioWatch pathogen surveillance program following a highly critical investigative article published by a major newspaper last month (see LA Times Slams BioWatch Program, July 9).
Days after the LA Times published the article, Alexander Garza, Chief Medical Officer for the Department of Homeland Security (DHS), responded with The Truth About BioWatch: The Importance of Early Detection of a Potential Biological Attack.
Northrop Grumman, a competitor for the upcoming BioWatch Gen-3 Phase II acquisition, also issued a press release that same week announcing their Next Generation Automated Detection System (NG-ADS) technology had successfully completed rigorous field testing (see Northrop Grumman Completes Field Tests for Biodetection System, July 11).
Read more at CIDRAP: Public health officials respond to critique of BioWatch
